CaterinaGianniniMD

PubMed

• 5 citations
  cIMPACT-NOW update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas.
  Felix Sahm, Kenneth D Aldape, Priscilla K Brastianos, Daniel J Brat, Sonika Dahiya
  Neuro-Oncology. 2025-02-10
• cIMPACT-NOW update 9: Recommendations on utilization of genome-wide DNA methylation profiling for central nervous system tumor diagnostics.
  Kenneth Aldape, David Capper, Andreas von Deimling, Caterina Giannini, Mark R Gilbert
  Neuro-Oncology Advances. 2025-01-03
• 2 citations
  Posterior pituitary tumors and other rare entities involving the pituitary gland.
  Federico Roncaroli, Caterina Giannini
  Brain Pathology. 2025-01-01

Journal Articles

• A Novel Enhancer Regulates MGMT Expression and Promotes Temozolomide Resistance in Glioblastoma  
  Ian F Parney, Fredric B Meyer, Caterina Giannini, Jann N Sarkaria, Nature
• Heterogeneity Within the PF-EPN-B Ependymoma Subgroup  
  Andrew Grossbach, Vijay Ramaswamy, Benjamin Lu, Mariarita Santi, Caterina Giannini, Linda M Liau, Terri S Armstrong, Sarah Leary, Matthias A Karajannis, Kenneth Aldape..., Acta Neuropathologica
• FGFR1:TACC1 Fusion Is a Frequent Event in Molecularly Defined Extraventricular Neurocytoma  
  Caterina Giannini, MD, Acta Neuropathologica
• Subependymal Giant Cell Astrocytoma-like Astrocytoma: A Neoplasm with a Distinct Phenotype and Frequent Neurofibromatosis Type-1-Association  
  Murat Gokden, Fausto J Rodriguez, Mark Jentoft, Chetan Bettegowda, Caterina Giannini, Aditya Raghunathan, Doris Lin, Nature
• Low‐Grade Fibromyxoid Sarcoma Arising Within the Median Nerve  
  Caterina Giannini, Kimberly K Amrami, Andrew L Folpe, Rachael A Vaubel, Neuropathology
• The Dangers of the “Head Down” Position in Patients with Untreated Pituitary Macroadenomas: Case Series and Review of Literature  
  Michael J Link, Satoshi Kiyofuji, Caterina Giannini, Pituitary
• Join now to see all